Chimeracore raises $9.0M
Santa Barbara-based Chimeracore, a firm developing bio-therapeutics and synthetic drugs, has quietly raised $9.0M in a venture funding round.
Boulder-based Occipital, the developer of mobile applications now working on 3D, panoramic imaging tools, has raised $7.0M in a new funding round, according to a regulatory filing from the firm this week.